REGULATORY

• Japan to Soon Start Taking Applications for Antibiotic Revenue Guarantee Program
  September 6, 2023

• MHLW to Launch Working Group on Drug Supply Info on Sept. 7
  September 5, 2023

• 23 Suspected Violations in Promotion Activities Reported in FY2022: MHLW
  September 5, 2023

• Dispensing Pharmacy Chief Nabbed for Obstruction of Public Bid
  September 4, 2023

• Japan Launches Agency for Infectious Disease Crisis Management
  September 4, 2023

• Relief Claims OK’ed for 54 More Deaths after COVID Vaccination
  September 4, 2023

• Japan Approves Pfizer’s Omicron XBB.1.5 Vaccine, Moderna’s Still under Review
  September 4, 2023

• MHLW Rejigs Organization, Infectious Disease Control Team Boots Up
  September 1, 2023

• Industry Requests Rewards for SaMDs that Help Doctors’ Workstyle Reform
  September 1, 2023

• Japan to Decide on COVID Health Funding from October, Assuming Shift to Normalcy Next Spring: Minister
  September 1, 2023

• MHLW Must Streamline Operations via DX, Improve Staff’s Work-Life Balance: Official
  September 1, 2023

• 8 New Cases of Unintentional Xocova Use Among Pregnant Patients, Adding Up to 15
  August 31, 2023

• Chuikyo Payer Rep Floats Deferred Price Cuts for PMP upon Generic Entries
  August 31, 2023

• MHLW Top Pharma Officer Remains Committed to Fast, Safe Access to Good Drugs
  August 31, 2023

• MHLW to Unveil Draft of 2nd Package Strategy for SaMD on Sept. 6
  August 31, 2023

• MHLW to Issue Development Requests for New Uses of Rituxan, Truvada, and More
  August 31, 2023

• Medical DX Office to Kick Off in September, Explore Better Use of Medical Data for Drug Discovery
  August 30, 2023

• MHLW Orders Label Revisions for Prazaxa, Smyraf, and More
  August 30, 2023

• MHLW Panel OKs Inclusion of 5-in-1 Vaccine in National Immunization Program
  August 30, 2023

• Label Revisions Ordered for CAR-T Therapies on Out-of-Spec Products
  August 30, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 72
• 73
• 74
• 75
• 76
• 77
• 78
• 79
• 80
• …
• Next ›
• 最終 »